90026492 - VIVA

Information

  • Trademark
  • 90026492
  • Serial Number
    90026492
  • Filing Date
    June 29, 2020
    4 years ago
  • Transaction Date
    January 30, 2024
    11 months ago
  • Status Date
    July 18, 2022
    2 years ago
  • Published for Opposition Date
    April 20, 2021
    3 years ago
  • Location Date
    June 15, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SETTLES LEWIS, SHAILA
  • Attorney Docket Number
    22184
    Attorney Name
    Howard N. Aronson
    Law Office Assigned Location Code
    M50
  • Owners
Mark Drawing Code
5000
Mark Identification
VIVA
Case File Statements
  • DM0000: The mark consists of the text "VIVA" in stylized lettering.
  • GS0091: Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and protein; Scientific apparatus, namely, cellular mixed ester membranes for use in the science and research industry; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses; Laboratory chemical reactors; Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics, and contaminants; Portable detection and identification instruments using light sources and light detectors for detecting and identifying chemical and biological substances not for medical purposes; Laboratory apparatus and chromatography systems for use in protein purification; Laboratory apparatus and computer systems for use in protein purification; Laboratory apparatus and instruments for extracting protein, not for medical purposes; Laboratory apparatus and instruments for extracting DNA, not for medical purposes; Solid phase extraction cartridges for laboratory use; Chromatography apparatus for laboratory use
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0351: Pharmaceutical cost management services and drug utilization review services; Providing an online computer database for collecting and reporting controlled substance prescription drug dispensing information for business purposes; Online retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies, via in-store order pickup; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
  • GS0011: Reagents for scientific and research use; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Chemicals for use in the purification of proteins for in vitro use; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Kit containing pre-packed columns, chemicals, pre-made buffer concentrates, syringes and instructional manual for the purification of proteins for in vitro use; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Protein in raw material form for scientific and medical research; Protein arrays and nucleotide arrays for scientific and medical research; Chemical preparations for scientific purposes; Stem cells for research or scientific purposes; Enzymes for use in protein hydrolysis; Chromatography chemicals; Electrophoresis gels; Electrophoresis gels other than for medical or veterinary purposes
  • GS0441: Medical equipment rental; Performing diagnosis of diseases; Medication consultation; Medical consultation; Medical auxiliary services being medical services; Medical services; Chemotherapy services; Stem cell treatment services; Medical clinic services; Medical treatment of cancer; Human tissue bank services; Genetic screening for medical purposes; Genetic testing for medical purposes; Medical analysis services for cancer diagnosis; Human blood collection and preservation; Medical analysis services provided by medical laboratories for diagnosis and treatment purposes
  • GS0421: Drug evaluation, namely, pharmaceutical product evaluation; Drug research services, namely, pharmaceutical research services; drug discovery services; implementation of early evaluations in the field of new drugs; scientific investigations for medical purposes; scientific laboratory services; laboratory equipment and instrument rental; chemical analysis services; biochemical research and analysis; Chemical research and analysis; Scientific research on the mechanism of action of compound use in animals; development and testing of chemical production methods; chemical analysis; chemical synthesis evaluation services; medical research; medical laboratory services; genome structure and function analysis; stem cell research services; Blood analysis services; Biotechnology research services; medical research services; biomedical research services; Genetic screening for scientific research purposes; antibody research and development; genetic testing for scientific research purposes; development of pharmaceutical preparations and medicines; Conducting clinical trials for others; Drug testing, namely, testing of pharmaceuticals; Chemical testing; Functional testing of equipment and instruments; Information technology consulting services in the field of drug discovery; Cloud computing services featuring software for performing drug discovery processess; Computer programming for medical care
Case File Event Statements
  • 7/18/2022 - 2 years ago
    21 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 7/18/2022 - 2 years ago
    20 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 12/16/2021 - 3 years ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/14/2021 - 3 years ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/14/2021 - 3 years ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/14/2021 - 3 years ago
    16 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/15/2021 - 3 years ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/20/2021 - 3 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/20/2021 - 3 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/31/2021 - 3 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/18/2021 - 3 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/10/2021 - 3 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/10/2021 - 3 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/9/2021 - 3 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 12/6/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/30/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/30/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/30/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/30/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/26/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/2/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP